Aspirin may decrease risk of aggressive form of ovarian cancer
- Details
- Category: Research
New research shows that women who regularly use pain relief medications, particularly aspirin, have a decreased risk of serous ovarian cancer - an aggressive carcinoma affecting the surface of the ovary. The study published in Acta Obstetricia et Gynecologica Scandinavica reports that non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs), paracetamol (acetaminophen), or other analgesics did not decrease ovarian cancer risk.
Rare disease researchers notch a win for patients with inherited muscle disease
- Details
- Category: Research
An older medication originally approved to treat heart problems eases the symptoms of a very rare muscle disease that often leaves its sufferers stiff and in a good deal of pain, physicians and researchers report in the Journal of the American Medical Association.
Discovery leads to new hope against ovarian cancer
- Details
- Category: Research
Scientists at USC have discovered a new type of drug for the treatment of ovarian cancer that works in a way that should not only decrease the number of doses that patients need to take, but also may make it effective for patients whose cancer has become drug-resistant.
New antibiotic cures disease by disarming pathogens
- Details
- Category: Research
A new type of antibiotic can effectively treat an antibiotic-resistant infection by disarming instead of killing the bacteria that cause it. Researchers report their findings in the October 2 issue of mBio®, the online open-access journal of the American Society for Microbiology.
Biological markers increase clinical trial success rate of new breast cancer drugs
- Details
- Category: Research
Using biological markers - genetic characteristics that are associated with some patients with breast cancer - can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research from the University of Toronto Mississauga.
Can disclosure hurt the translation of research?
- Details
- Category: Research
All major clinical trials now include disclosures detailing who funded the study to ensure transparency. However, is it possible that this transparency is actually hurting research? One might assume that the methodological rigor of the study matters to physicians more than the disclosure.
Statins are unlikely to prevent blood clots
- Details
- Category: Research
Despite previous studies suggesting the contrary, statins (cholesterol-lowering drugs) may not prevent blood clots (venous thrombo-embolism) in adults, according to a large analysis by international researchers published in this week's PLOS Medicine. In 2009, an additional analysis of data from a randomized controlled trial called the JUPITER trial reported that the statin rosuvastatin halved the risk of venous thromboembolic events among apparently healthy adults.
More Pharma News ...
- Light drinking may relate to increase in risk for certain cancers
- Researchers reveal underlying mechanism of powerful chemotherapy for prostate cancer treatment
- Considerably more patients may benefit from effective antidiabetic drug
- Double drug combo could shut down abnormal blood vessel growth
- Large lung cancer study shows potential for more targeted therapies
- Nutritional supplement offers promise in treatment of unique form of autism
- Male birth control pill may be ready soon